Form 4: AtriCure COO Douglas J. Seith Reports Stock Transactions

AtriCure's Chief Operating Officer, Douglas J. Seith, reports acquisition and disposal of company stock, including shares from restricted stock and performance share awards.

Summary

• Douglas J. Seith, the Chief Operating Officer of AtriCure, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2024, Seith acquired 37,899 shares of common stock through a restricted stock award and 19,205 shares through the vesting of a performance share award, both at $0.
• On the same day, Seith disposed of 14,596 shares at $36.28 to cover tax withholding obligations.
• Following these transactions, Seith beneficially owns 153,520 shares of AtriCure common stock.
• The restricted stock award vests in three equal annual installments.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing reflects standard executive compensation practices and tax management.

Positives

• The vesting of restricted stock and performance share awards indicates that the company and the executive are meeting certain performance goals.

Negatives

• The disposal of shares to cover tax obligations, while common, slightly reduces the executive's stake in the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates normal compensation and tax-related transactions.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.

Key Dates